EPAD exhibits at AAIC in Chicago

We are pleased that for the first time during our project, we exhibited the EPAD study at the Alzheimer’s Association International Conference (AAIC) held on 22-26 July. With its neat white walls and signature green colours, the EPAD booth at the start of the exhibition area at this year’s record size AAIC in Chicago stood…

Interview with Johannes Streffer

What is your current role in EPAD? I have recently joined the executive committee of EPAD. The executive committee is suggested to follow up on the project to see if everything is performed as planned and help coordinate between different ongoing activities. As well, it is a group that can react to new developments e.g.…

Interview with Saira Ramasastry

What is your current role in EPAD? I am a member of Work Package 7 focusing on business and sustainability for the EPAD project. We are conducting analysis pertaining to markets, stakeholders, incentive, IP and financial strategy. Ultimately, we are collaborating with the entire consortium to create a feasible business plan for the EPAD machine.…

José Luis Molinuevo presents European research initiatives on Alzheimer’s Prevention in Japan

The scientific director of the Alzheimer’s Prevention Research Program at the Barcelonaβeta Brain Research Center, José Luis Molinuevo, presented in Japan the EPAD project, in two conferences about European research initiatives on Alzheimer’s disease Prevention. On July 2nd, he participated in a session on Alzheimer’s disease at the 18th World Congress of Basic and Clinical…

Our sister project AMYPAD enrols its first research participant

Our sister project, Amyloid imaging to prevent Alzheimer’s disease (AMYPAD), which began its activities on October 2016, has recently enrolled its first research participant. The first participant was recruited in Geneva, Switzerland, within the diagnostic and patient management sub-study (DMPS) of the AMYPAD project. In this clinical study, researchers aim to include subjects suspected of possible…